pharmaphorum

FEBRUARY 21, 2024

Clinical research involves trial and error as part of the drug development process. Learn more about how to optimise drug trials and the important role of participants in clinical research.

124

124

Outsourcing Pharma

JUNE 15, 2023

The digital biomarkers company has partnered with Beacon Biosignlas, a computational neurodiagnostics company to launch a clinical trial investigate the integration of Beaconâs at-home electroencephalogram (EEG) into Koneksaâs neuroscience solution toolkit.

52

52

Fierce Pharma

MARCH 21, 2024

Drug developers often try to spot tidbits of positive information from a failed clinical trial. Drug developers often try to spot tidbits of positive information from a failed clinical trial.

101

101

European Pharmaceutical Review

APRIL 4, 2024

million initiative announced on 21 March is set to accelerate advanced therapy development in the UK. The scheme aims to support UK advanced therapy medicinal product (ATMP) clinical trials. What key solutions will the investment in the Advanced Therapy Treatment Centre Network provide?

88

88

Outsourcing Pharma

APRIL 29, 2024

OSP spoke to Berkeley Research Group healthcare managing director, Wendy Cheng for a discussion around developments in AI regulation for pharmaceuticals, clinical trials, and drug development at a global scale.

71

71

Outsourcing Pharma

MAY 25, 2023

A company developing small molecule therapeutics targeting DNA Damage Response (DDR) in order to treat patients with a broad range of cancers has its first assay development customer.

52

52

European Pharmaceutical Review

MARCH 5, 2024

BeiGene has appointed Pilar de la Rocha as its new Head of Europe, Global Clinical Operations. The biotech’s new appointment underlines its commitment to advancing clinical development initiatives in the European region. The company highlighted that 35 percent of patients enrolled in its clinical trials are based in Europe.

Medical Schools 94

Medical Schools 94

Fierce Pharma

JULY 12, 2023

Author: Mike Cioffi, Senior Vice President, Clinical Solutions and Strategic Development, WCG | Patients need to be involved in developing ePRO assessments from the outset, especially for endpoints without existing standards or scales. Ideally, sponsors

52

52

pharmaphorum

JANUARY 12, 2024

AI technology is revolutionising the field of clinical trials by enhancing patient identification, accelerating drug development and design, and improving monitoring processes. Discover how AI is supercharging clinical trials for better healthcare outcomes.

105

105

pharmaphorum

MARCH 11, 2024

Stay updated on the latest developments in clinical trials with highlights from Medigene, Artax, and KalVista from 12th to 16th February 2024.

109

109

STAT

OCTOBER 31, 2023

This article was adapted from STAT’s latest report , “Subgroup analysis: how to evaluate post hoc tests for significance in failed clinical trials.” ” C linical trials of newly developed drugs often don’t work out. Read the rest…

134

134

STAT

NOVEMBER 1, 2023

An important Phase 3 trial has shown that a new drug that targets gonorrhea works as well as the last existing antibiotic to treat the sexually transmitted infection, results that could lead to licensure of the first new treatment for gonorrhea in decades. released topline results of the clinical trial on Wednesday.

145

145

European Pharmaceutical Review

APRIL 18, 2024

New trial results for GSK’s oral gepotidacin, a potential first-in-class oral antibiotic, has shown that it was non-inferior with 92.6 More about the EAGLE-1 trial for the antibiotic gepotidacin The global phase III clinical programme for gepotidacin in adults and adolescents involved three clinical trials.

100

100

pharmaphorum

FEBRUARY 8, 2024

Gilead Sciences has said it will no longer develop its CD47-targeting antibody magrolimab in blood cancers after data suggested that patients taking the drug in clinical trials were more likely to die than those in control groups.

116

116

STAT

NOVEMBER 6, 2023

SAN DIEGO — Ventyx Biosciences reported on Monday that it was ending development of an experimental drug for treating plaque psoriasis though it proved safe and moderately effective in a mid-stage trial. Within hours, the company’s stock tanked by more than 80%. Shares in Ventyx plummeted from $14.09

120

120

STAT

DECEMBER 21, 2023

WASHINGTON — Sometime next year drug and medical device companies will have to tell the Food and Drug Administration how they plan to include people of color in clinical trials. Congress in late 2022 passed a law requiring companies to give FDA their plans for diversifying clinical trials.

FDA 137

FDA 137

STAT

OCTOBER 6, 2023

Califf proposed something radical: that private health care insurance companies (payers) should participate in clinical research on FDA-approved drugs. This challenges the prevailing convention that only drug developers conduct such studies — and it’s an idea worth considering.

FDA 109

FDA Insurance 109

pharmaphorum

JANUARY 8, 2024

Stay up to date with the latest developments in clinical trials, including updates on Vicore, Mundipharma, Agios, Ultragenyx, EG 427, Orion, and MSD. Find out what these companies are working on and their potential impact on healthcare.

113

113

European Pharmaceutical Review

JANUARY 18, 2024

An attractive destination for ATMP clinical trials Based on the Cell and Gene Therapy Catapult (CGT Catapult)’s recently published UK 2023 Advanced Therapy Medicinal Product (ATMP) Clinical Trials Database , the UK is an attractive location for ATMP clinical trials.

101

101

STAT

DECEMBER 1, 2023

Pfizer on Friday said it was stopping development of a twice-daily oral obesity medication after an underwhelming clinical trial, a blow to the company’s efforts to compete in the booming field of weight-loss medications.

140

140

European Pharmaceutical Review

JANUARY 24, 2024

The first in our inaugural Pharma Horizons report series is dedicated to exploring the latest advances in artificial intelligence (AI) and machine learning (ML) for drug development, pharmaceutical manufacturing and quality control. Additionally the pharmaceutical AI market is projected to reach $11.8 Download for free today!

128

128

Drug Store News

OCTOBER 4, 2022

CVS Health Clinical Trial Services was launched in 2021 with the goal of developing and executing a community-centric model for clinical trials.

137

137

STAT

DECEMBER 13, 2023

In 2016, a trial for a hormonal male birth control pill was halted after men reported side effects including acne and mood swings — though such side effects are also experienced by women on various hormonal contraceptives. The pill entered its Phase 1 clinical trial today in the U.K.,

141

141

Outsourcing Pharma

APRIL 3, 2024

Dr Laura Trotta joined CluePoints in 2015 and moved into her current role as vice president of research in January 2022, where she leads a team of research scientists responsible for developing new statistical and machine learning algorithms to assess the quality of clinical trial data.

87

87

STAT

APRIL 2, 2024

The news represents a setback for an ambitious project to not only bring forward one of the first gene-editing treatments in humans, but to also do so not for a rare condition but for the leading killer in the developed world.

Compounding 125

Compounding 125

pharmaphorum

FEBRUARY 8, 2024

Stay up to date with the latest updates in the world of clinical trials. This week's highlights include Bayer's new study on aflibercept, BioNTech's groundbreaking research, and the exciting developments from Duality Bio. Get all the important information here.

102

102

pharmaphorum

MARCH 8, 2024

Amongst Novo Nordisk's comprehensive business update to investors, attention latched onto early data for an oral obesity therapy that outperformed the company’s big-selling GLP-1 agonist Wegovy in a clinical trial.

101

101

European Pharmaceutical Review

APRIL 12, 2024

vosoritide] is the first medicine that has been developed to specifically target the pathway involved in hypochondroplasia” “This is the first medicine that has been developed to specifically target the pathway involved in hypochondroplasia,” commented Dr Andrew Dauber, Chief of Endocrinology at Children’s National Hospital in the US.

Hospitals 76

Hospitals 76

STAT

MARCH 29, 2023

A growing shortage of monkeys used for early-stage pharmaceutical research is causing concern that many companies will soon face costly delays starting clinical trials — leading to a slowdown in drug development. In recent weeks, the U.S

130

130

STAT

NOVEMBER 7, 2023

WASHINGTON — Current and former government officials proffered a clear-eyed, and often depressing, take Tuesday on the state of clinical trials, the pharmaceutical industry, and biotech investors coming out of the Covid-19 pandemic. Continue to STAT+ to read the full story…

Vaccines 120

Vaccines FDA 120

STAT

JANUARY 30, 2024

A pain relief drug developed by Vertex Pharmaceuticals succeeded in late-stage clinical trials, the company announced Tuesday, bringing the biopharma giant a step closer to launching what observers believe could be a potential blockbuster and upending decades of pharma failure in a complicated field.

132

132

STAT

OCTOBER 16, 2023

People with obesity often go underrepresented in drug development trials, a critical gap that researchers say leaves drugmakers and doctors unsure of efficacy or risks in that patient population. “People with obesity are underrepresented in clinical trials for drug approval.” ” Read the rest…

124

124

STAT

APRIL 4, 2024

Bankruptcies, restructurings, clinical trial setbacks, and falling stock prices: It’s been a disconcerting week in Biotech Land. Today, the company is developing a treatment for obesity that was discovered through research into marijuana, and that might be additive to the GLP-1 blockbusters. I want to hear from you!

109

109

European Pharmaceutical Review

DECEMBER 15, 2023

Moderna and MSD have announced follow-up data from the Phase IIb clinical trial evaluating cancer vaccine mRNA-4157 (V940) in combination with MSD’s Keytruda in patients with resected high-risk melanoma. Both trials are enrolling patients. The companies also plan to expand the development programme to additional tumour types.

Vaccines 100

Vaccines Research Laboratories Immunization 100

Outsourcing Pharma

MARCH 18, 2024

On Friday (March 15) leading pharma Auxilius Pharma announced promising results from the first-in-human clinical trial of its originative product-in-development, AUX-001.

73

73

STAT

MARCH 20, 2024

is working on a new type of T-cell engager developed by Johns Hopkins researchers Bert Vogelstein and Drew Pardoll. Critically, that funding will be enough to bring the company into clinical trials and gather early proof-of-concept clinical data.    Clasp, which has dual headquarters in Cambridge, Mass.,

131

131

European Pharmaceutical Review

AUGUST 21, 2023

According to a market report , the global RNA therapy clinical trials market is anticipated to reach $3.5 This has therefore led to a rise in the number of RNA clinical trials being conducted. Thus, this has driven growth of the RNA therapy clinical trials market. billion by 2030 and grow at a CAGR of 3.84

Vaccines 93

Vaccines 93